New device, ‘old’ allergens. Allergic contact dermatitis caused by the Dexcom G7 glucose sensor

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Martin Mowitz, Sarah Hosseini, Ingrid Siemund, Josefin Ulriksdotter, Cecilia Svedman
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867021648688840704
author Martin Mowitz
Sarah Hosseini
Ingrid Siemund
Josefin Ulriksdotter
Cecilia Svedman
author_facet Martin Mowitz
Sarah Hosseini
Ingrid Siemund
Josefin Ulriksdotter
Cecilia Svedman
Martin Mowitz
Sarah Hosseini
Ingrid Siemund
Josefin Ulriksdotter
Cecilia Svedman
collection Wiley Open Access
contents New device, ‘old’ allergens. Allergic contact dermatitis caused by the Dexcom G7 glucose sensor Martin Mowitz Sarah Hosseini Ingrid Siemund Josefin Ulriksdotter Cecilia Svedman Contact Dermatitis AbstractBackgroundAllergic contact dermatitis (ACD) has been reported as an adverse effect from the use of several glucose sensors and insulin pumps from different manufacturers. Isobornyl acrylate (IBOA) has been identified as a major culprit sensitizer, but also other acrylates and (modified) colophonium have been reported as causes of ACD.ObjectivesTo report the two first cases diagnosed with ACD caused by the Dexcom G7 (DG7) glucose sensor.Patients and MethodsTwo children with suspected ACD from DG7 were patch tested with our medical device series with an addition of selected test preparations including two variants of modified colophonium – methyl hydrogenated rosinate (MHR) and glyceryl hydrogenated rosinate (GHR). Both patients were also tested with acetone extracts made from different parts of the DG7 sensor. The extracts were analysed by gas chromatography–mass spectrometry (GC–MS).ResultsBoth patients tested positive to IBOA, hydroabietyl alcohol and GHR. In addition, patient 1 had a positive reaction to MHR and patient 2 had a positive reaction to colophonium. The GC–MS analyses showed the presence of IBOA and colophonium‐related substances in the DG7 extracts.ConclusionsBoth patients were diagnosed with contact allergy to well‐known medical device‐related sensitizers. The presence of IBOA and (modified) colophonium in a newly introduced (on the Swedish market in 2023) glucose sensor is remarkable and indicates an inadequate toxicological assessment of the materials used in the sensor. 10.1111/cod.14514 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1111/cod.14514
format Artículo Open Access
id wiley_oa_10_1111_cod_14514
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle New device, ‘old’ allergens. Allergic contact dermatitis caused by the Dexcom G7 glucose sensor
Martin Mowitz
Sarah Hosseini
Ingrid Siemund
Josefin Ulriksdotter
Cecilia Svedman
Contact Dermatitis
New device, ‘old’ allergens. Allergic contact dermatitis caused by the Dexcom G7 glucose sensor Martin Mowitz Sarah Hosseini Ingrid Siemund Josefin Ulriksdotter Cecilia Svedman Contact Dermatitis AbstractBackgroundAllergic contact dermatitis (ACD) has been reported as an adverse effect from the use of several glucose sensors and insulin pumps from different manufacturers. Isobornyl acrylate (IBOA) has been identified as a major culprit sensitizer, but also other acrylates and (modified) colophonium have been reported as causes of ACD.ObjectivesTo report the two first cases diagnosed with ACD caused by the Dexcom G7 (DG7) glucose sensor.Patients and MethodsTwo children with suspected ACD from DG7 were patch tested with our medical device series with an addition of selected test preparations including two variants of modified colophonium – methyl hydrogenated rosinate (MHR) and glyceryl hydrogenated rosinate (GHR). Both patients were also tested with acetone extracts made from different parts of the DG7 sensor. The extracts were analysed by gas chromatography–mass spectrometry (GC–MS).ResultsBoth patients tested positive to IBOA, hydroabietyl alcohol and GHR. In addition, patient 1 had a positive reaction to MHR and patient 2 had a positive reaction to colophonium. The GC–MS analyses showed the presence of IBOA and colophonium‐related substances in the DG7 extracts.ConclusionsBoth patients were diagnosed with contact allergy to well‐known medical device‐related sensitizers. The presence of IBOA and (modified) colophonium in a newly introduced (on the Swedish market in 2023) glucose sensor is remarkable and indicates an inadequate toxicological assessment of the materials used in the sensor. 10.1111/cod.14514 http://creativecommons.org/licenses/by-nc-nd/4.0/
title New device, ‘old’ allergens. Allergic contact dermatitis caused by the Dexcom G7 glucose sensor
topic Contact Dermatitis
url https://onlinelibrary.wiley.com/doi/10.1111/cod.14514